medigraphic.com
SPANISH

Archivos de Medicina de Urgencia de México

ISSN 2594-3006 (Electronic)
ISSN 2007-1752 (Print)
Archivos de Medicina de Urgencia de México
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 2-3

<< Back Next >>

Arch Med Urg Mex 2025; 17 (2-3)

Frequency and treatment of obstetric hemorrhage in the puerperium of patients with preeclampsia, who were treated in the Intensive Care Unit of the Gynecology and Obstetrics Hospital of the National Medical Center “La Raza”

Díaz-Aguilar FA, Flores-Espindola NS, Vázquez-Rodríguez JG, Méndez-Yebra MÁ, Mendoza-Reyes E, Tovar-Galván V
Full text How to cite this article 10.35366/122677

DOI

DOI: 10.35366/122677
URL: https://dx.doi.org/10.35366/122677

Language: Spanish
References: 19
Page: 95-104
PDF size: 340.22 Kb.


Key words:

preeclampsia, hemorrhage, transfusion, antihypertensive.

ABSTRACT

Introduction: in Mexico, the two main causes of maternal morbidity and mortality are obstetric hemorrhage and hypertensive disorders of pregnancy.
Materials and Methods: study design: analytical, observational, descriptive, retrospective, and cross-sectional study in patients diagnosed with obstetric hemorrhage in the puerperium of women with preeclampsia. The records of patients admitted to the intensive care unit (ICU) of the highly specialized gynecology and obstetrics unit of the La Raza National Medical Center from October 2019 to May 2024 were used. Data were collected on demographics, comorbidities, vital signs, laboratory results before and after the hemorrhage, route of pregnancy resolution, amount of hemorrhage, fluids, medical and surgical treatment, transfusions, length of stay in the ICU, use of mechanical ventilation, disseminated intravascular coagulation, and death. Two groups were divided into groups with and without magnesium administration, with mean blood pressure (MAP) less than or greater than 126, and corresponding statistical differences were obtained. Statistical analysis was performed using SPSS25.
Results: sixty patients (8.7%) met the inclusion criteria. The most common age was 35 years, and the gestational age was 34.4 weeks. At the time of admission to intensive care, the median systolic blood pressure was 160 mmHg, and the diastolic blood pressure was 99 mmHg. Neuroprotection with magnesium sulfate was given to 24 patients (40%). The median (M) estimated blood loss at the time of termination of pregnancy was 1,550 ml. The preoperative hemoglobin level was 12.5 g/dl and 10.0 g/dl after surgery, and the platelet level was 163,000 and 117,000, respectively.
The minimum number of milliliters of blood transfused was 250 cc in 11 patients (18.3%) and the maximum was 5,750 ml in 1 patient (1.7%). Fresh frozen plasma (FFP) was used in 19 patients (35.1%), and cryoprecipitate (CP) was used in 14 (23.4%). The use of amines was recorded in 10 patients (17.6%), with invasive mechanical ventilation required in 15 patients (25%). Among the complications reported during their intensive care stay, 9 patients (15%) presented acute kidney injury, 2 (3.3%) presented disseminated intravascular coagulation (DIC), and one death was reported (1.4%).
Comparisons of the two groups with and without magnesium showed statistical significance with the INR (p=0.03) and the PT (p=0.023). Significant differences were found between MAP levels below and above 126, with respect to platelets (p=0.018), PT (p=0.23), and bleeding (p=0.001).
Conclusions: these two conditions in the same patient pose a medical challenge, as the same hypertensive disorders of pregnancy increase the amount of bleeding, and the established treatments differ: antihypertensives are used, while resuscitation is provided with blood products and solutions to improve the hemodynamic status of our patients. The use of magnesium did not show an increase in bleeding, although bleeding did increase with high blood pressure.


REFERENCES

  1. Dirección General de Epidemiología. Sistema nacional de vigilanciaepidemiológica, Boletín Epidemiológico, Semana 11, 2024;

  2. Committee on Practice Bulletins-Obstetrics. Practice BulletinNo. 183: Postpartum Hemorrhage. Obstet Gynecol.2017;130(4):e168-e186

  3. Mavrides E, Allard S, Chandraharan E, Collins P, Green L, HuntBJ, Riris S, Thomson AJ on behalfof the Royal College of Obstetriciansand Gynaecologists. Prevention and management of postpartumhaemorrhage. BJOG 2016;124:e106–e149.

  4. Nyfløt LT, Sandven I, Stray-Pedersen B, Pettersen S, Al-Zirqi I,Rosenberg M, Jacobsen AF, Vangen S. Risk factors for severepostpartum hemorrhage: a case-control study. BMC PregnancyChildbirth. 2017 Jan 10;17(1):17.

  5. Wilbeck J, Hoffman JW, Schorn MN. Postpartum Hemorrhage:Emergency Management for Uncontrolled Vaginal Bleeding. AdvEmerg Nurs J. 2022 Jul-Sep 01;44(3):213-219.

  6. Akaishi T, Tarasawa K, Hamada H, Iwama N, Tomita H, Akaishi M,Fushimi K, Fujimori K, Yaegashi N, Saito M. Prenatal hypertensionas the risk of eclampsia, HELLP syndrome, and critical obstetrichemorrhage. Hypertens Res. 2024 Feb;47(2):455-466.

  7. Prevención y manejo de la hemorragia postparto. Guía de PrácticaClínica: Evidencias y Recomendaciones. México, CENETEC;2021

  8. Oyelese Y, Ananth CV. Postpartum hemorrhage: epidemiology,risk factors, and causes. Clin Obstet Gynecol. 2010;53(1):147-56.

  9. Chaemsaithong, P., Sahota, D. S., & Poon, L. C. (2022). First trimesterpreeclampsia screening and prediction. American journalof obstetrics and gynecology, 226(2S), S1071–S1097.e2.

  10. Jung, E., Romero, R., Yeo, L., Gomez-Lopez, N., Chaemsaithong,P., Jaovisidha, A., Gotsch, F., & Erez, O. (2022). The etiology ofpreeclampsia. American journal of obstetrics and gynecology,226(2S), S844–S866.

  11. Yagel, S., Cohen, S. M., & Goldman-Wohl, D. (2022). An integratedmodel of preeclampsia: a multifaceted syndrome of the maternalcardiovascular-placental-fetal array. American journal ofobstetrics and gynecology, 226(2S), S963–S972.

  12. Prevención, diagnóstico y tratamiento de la Preeclampsia en segundoy tercer nivel de atención, Instituto Mexicano del SeguroSocial; México, CENETEC 2017.

  13. Masini, G., Foo, L. F., Tay, J., Wilkinson, I. B., Valensise, H., Gyselaers,W., & Lees, C. C. (2022). Preeclampsia has two phenotypeswhich require different treatment strategies. American journal ofobstetrics and gynecology, 226(2S), S1006–S1018.

  14. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH,Ford JB, et al. Trends in postpartum hemorrhage in high resourcecountries: a review and recommendations from the International.International Postpartum Hemorrhage Collaborative Group. BMCPregnancy and Childbirth 2009;9:55.doi:10.1186/1471-2393

  15. Sparr H, Beaufort, T, Fuchs-Buder T.: Newer neuromuscular blockingagents. Drugs 2001; 61(7): 919 –942

  16. Díaz-Aguilar FA, Penagos-Hernández DH, Flores-Meza MÁ. Valoresde la gasometría arterial y lactato sérico transoperatorio enpacientes con hemorragia obstétrica que ingresaron a una unidadde terapia intensiva. Med Crit. 2023;37(5):411-418.

  17. Huang CR, Xue B, Gao Y, Yue SW, Redding SR, Wang R, OuyangYQ. Incidence and risk factors for postpartum hemorrhageafter vaginal delivery: A systematic review and meta-analysis. JObstet Gynaecol Res. 2023 Jul;49(7):1663-1676.

  18. Von Schmidt auf Altenstadt JF, Hukkelhoven CWPM, van RoosmalenJ, Bloemenkamp. Pre-Eclampsia Increases the Risk ofPostpartum Haemorrhage: A Nationwide Cohort Study in The Netherlands.PLoS ONE, 2013 December, 8(12): e81959.

  19. Pergialiotis V, Bellos I, Constantinou T, Voskos A, PapapanagiotouA, Loutradis D, Daskalakis G. Magnesium sulfate and risk ofpostpartum uterine atony and hemorrhage: A meta-analysis. Eur JObstet Gynecol Reprod Biol. 2021 Jan;256:158-164.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Med Urg Mex. 2025;17